Skip to content

13F-HR filed by TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 41 holding rows worth $2,201,787,906.

Accession
0001214659-26-010416
Filed
2026-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 41 entries on the cover page, a total value of $2,201,787,906 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,201,787,906 with VALUE read as dollars as filed, 13F file number 028-14822. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AURINIA PHARMACEUTICALS INC COM05156V102Stock13,044,106$221,358,479dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW1,892,200$167,989,516dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM1,236,027$144,701,681dollars as filed
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL AG52694109Stock2,259,889$144,519,902dollars as filed
CELCUITY INC15102K100COM1,314,594$137,532,824dollars as filed
CORCEPT THERAPEUTICS INC218352102COM1,500,000$130,425,000dollars as filed
PTC THERAPEUTICS INC69366J200COM1,500,000$122,355,000dollars as filed
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR3,785,991$113,504,010dollars as filed
CAPRICOR THERAPEUTICS INC14070B309COMMON STOCK4,099,900$98,725,592dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK1,568,266$98,706,662dollars as filed
SPY78462F103SHS123,000$91,852,710dollars as filed
ANAPTYSBIO INC032724106COM1,330,879$89,834,333dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR2,649,368$84,117,434dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS5,000,000$70,750,000dollars as filed
ANI PHARMACEUTICALS INC00182C103COM707,500$58,566,850dollars as filed
BIONTECH SE SPONSORED ADS09075V102ADR470,000$43,733,500dollars as filed
COMPASS THERAPEUTICS INC20454B104COM17,990,782$39,399,813dollars as filed
PRECIGEN INC74017N105COM6,417,500$36,579,750dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM1,792,626$32,930,540dollars as filed
NUVECTIS PHARMA INC67080T108COMMON STOCK1,550,000$28,504,500dollars as filed
DIANTHUS THERAPEUTICS INC252828108COM264,692$25,802,176dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK6,521,412$23,868,368dollars as filed
ATEA PHARMACEUTICALS INC04683R106COMMON STOCK4,814,700$22,388,355dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK1,160,000$20,880,000dollars as filed
NANO DIMENSION LTD63008G203SPONSORD ADS NEW14,292,813$20,724,579dollars as filed
VIKING THERAPEUTICS INC92686J106COM500,000$19,505,000dollars as filed
NUVATION BIO INC COM CL A67080N101Stock3,299,557$18,741,484dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock450,000$16,771,500dollars as filed
GOSSAMER BIO INC38341PAA0NOTE 5.000% 6/017,841,000$11,468,373dollars as filedprincipal
JOURNEY MED CORP48115J109COM1,610,000$11,398,800dollars as filed
INSMED INC COM PAR $.01457669307Stock100,000$10,662,000dollars as filed
STOKE THERAPEUTICS INC86150R107COM300,000$9,816,000dollars as filed
PLIANT THERAPEUTICS INC729139105COM6,141,261$7,001,038dollars as filed
BOUNDLESS BIO INC10170A100COM2,559,875$6,399,688dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM4,245,085$5,688,414dollars as filed
MODERNA INC60770K107COM50,000$3,501,500dollars as filed
WAVE LIFE SCIENCES LTD SHSY95308105Stock600,000$3,486,000dollars as filed
HERON THERAPEUTICS INC427746102COM6,250,000$2,667,500dollars as filed
LENZ THERAPEUTICS INC52635N103COM451,114$2,562,328dollars as filed
ALTIMMUNE INC02155H200COM NEW666,022$2,024,707dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM100,000$342,000dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-26-010416this filing2026-08-14acceptance time not in the bulk data set